Hansa Biopharma AB (HNSBF)
3.00
0.00 (0.00%)
USD |
OTCM |
Mar 04, 16:00
Hansa Biopharma Debt to Equity Ratio: -1.807 for Dec. 31, 2024
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Abliva AB | -- |
| Oncopeptides AB | 0.8095 |
| BioInvent International AB | 0.00 |
| BioArctic AB | 0.00 |
| Camurus AB | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 72.63M |
| Total Liabilities (Quarterly) | 126.09M |
| Shareholders Equity (Quarterly) | -53.46M |
| Current Ratio | 2.294 |
| Net Debt Paydown Yield | -1.37% |